Home           |           About Us           |           Register Free           |           Events and Conferences           |           Contact Us

Bio-Bridge Science, Inc., a development stage biotechnology company, engages in the commercial development of vaccines for the prevention and treatment of human infectious diseases. The company is currently developing and commercializing HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV). It develops HIV vaccines for both preventive and therapeutic purposes. HIV-PV Vaccine I pre-clinical trials are near complete but the vaccine is not yet approved for Phase I clinical trials. The company holds the exclusive license for the HIV-PV Vaccine I technology with respect to China(including Hongkong,Macau and Taiwan), the United States, and Japan.

Website : www.bio-bridge-science.com

Wyeth is a global leader in pharmaceuticals, consumer health care products, and animal health care products.

Wyeth improves the lives of millions of people around the world with its outstanding products. And new, innovative medicines are on the way. With research and development (R&D) programs focused on small molecules, vaccines and biotechnology, Wyeth is exploring more than 60 new therapies for medical conditions such as diabetes, breast cancer, multiple sclerosis, HIV, Alzheimer’s disease and schizophrenia.

Website : www.wyeth.com

Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.

Website : www.amgen.com

As a global, broad-based health care company, Abbott build upon their internal scientific expertise to bring new products to market. Their work across their broad lines of business gives them a wealth of knowledge, understanding and capabilities in a number of health areas. This expertise helps them to advance medical science, enabling people to live healthier lives.

Website : www.abbott.com